The newly formed biotech start up Halo Therapeutics, spun out from the University of Bristol, has become the latest company to join the Science Creates ecosystem.
The team is targeting new treatments for coronavirus as they expand on their exciting recent breakthrough discovery, which was published in Science Magazine.
The context
New antiviral drugs offer the hope of broadening the range of treatments available to treat COVID-19. The recent findings by the Halo Therapeutics team have demonstrated that exposing the SARS-CoV-2 (Coronavirus) virus to a free fatty acid called linoleic acid locks the virus’s spike protein into a closed, non-infective form stopping it in its tracks.
Comments are closed.